Dan L Duncan Comprehensive Cancer Center Breast Cancer Symposium

Needs Statement

The landscape of breast cancer treatment is rapidly evolving with the introduction of novel therapeutics, personalized care models, and innovative surgical and radiation techniques. However, many community-based practitioners face challenges in staying current with these advancements, leading to inconsistent adoption of evidence-based practices. There is a critical need for education on new drug approvals, surgical and axillary management strategies, radiation de-escalation, and emerging therapies such as CAR-T cells. Additionally, the integration of genetic risk assessments into preventive care remains limited. This symposium aims to bridge these gaps by equipping healthcare providers with the latest multidisciplinary knowledge to enhance patient outcomes through individualized, up-to-date breast cancer care.

Educational Objectives

At the conclusion of the conference, participants should be able to:

• Review the latest updates from ASCO 2024 in the management of breast cancer.
• Discuss advanced surgical techniques in breast cancer and axilla management.
• Compare newer radiation modalities for breast cancer.
• Evaluate caveats in breast cancer imaging.
• Outline genetic screening strategies for primary prevention in high-risk patients.

Target Audience

Competencies

• Employ Evidence-Based Practice
• Interpersonal and Communication Skills
• Interprofessional Communication
• Medical Knowledge
• Patient Care and Procedural Skills
• Provide Patient-Centered Care
• Values/Ethics for Interprofessional Practice

Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and Dan L Duncan Comprehensive Cancer Center. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. 

Baylor College of Medicine designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.